For the year ending 2025-12-31, MRKR has $19,070,997 in assets. $2,274,183 in debts. $16,068,048 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 16,068,048 | |||
| Restricted cash | 974,799 | |||
| Prepaid expenses and deposits | 658,750 | |||
| Other receivables | 1,369,400 | |||
| Total current assets | 19,070,997 | |||
| Total assets | 19,070,997 | |||
| Accounts payable and accrued liabilities | 1,299,384 | |||
| Deferred revenue | 974,799 | |||
| Total current liabilities | 2,274,183 | |||
| Total liabilities | 2,274,183 | |||
| Common stock, 0.001 par value, 30 million shares authorized, 16.7 million and 10.7 million shares issued and outstanding as of december 31, 2025 and 2024, respectively (see note 7) | 16,672 | |||
| Additional paid-in capital | 475,960,940 | |||
| Accumulated deficit | -459,180,798 | |||
| Total stockholders' equity | 16,796,814 | |||
| Total liabilities and stockholders' equity | 19,070,997 | |||
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)